Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Mie University has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. This indicates a very concentrated prosecution effort, with all current activity focused on a single application within the biotechnology sector. The 1 pending office action represents the university's entire current workload at the USPTO.
BAEK, JONGHWAN NMN is the busiest examiner for the portfolio with the pending office action. Since there is only a single examiner and a single art unit, the outcome of the university's current patent efforts depends solely on the evaluation by BAEK, JONGHWAN NMN. This streamlined environment allows for a direct and focused prosecution strategy. Practitioners should note that the art unit will dictate the procedural framework for the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAEK, JONGHWAN NMN | 1 | 50.0% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18282829 | COMPOSITION FOR CONTRAST IMAGING OF CANCER | BAEK, JONGHWAN NMN | 1618 | §103DP | Final Rejection | — | Pending | Sep 19, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMie University has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jonghwan Nmn Baek has the most, with 1 of Mie University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.